Pershing Square Activist Presentation Deck
Healthcare Regulatory Impact (cont'd.)
Pharmaceutical Cos. - Aggregate Penalties ('91-July '12)
Company*
Percent of Totalt
Total Financial
Penalties
GlaxoSmithKline
Pfizer
Johnson & Johnson
Merck***
Abbott
Eli Lilly
Schering-Plough
AstraZeneca
TAP Pharmaceutical
Products
Novartis
Bristol-Myers Squibb***
Mylan
Serono
Purdue
Allergan
Daiichi Sankyo
Cephalon
Boehringer Ingelheim
Forest Laboratories
Sanofi
Other**
Total
$7.56 billion
$2.96 billion
$2.33 billion
$1.86 billion
$1.82 billion
$1.71 billion
$1.34 billion
$954 million
$875 million
$793 million
$789 million
$707 million
$704 million
$620 million
$600 million
$500 million
$425 million
$329 million
$315 million
$313 million
$1.88 billion
$29.35 billion
25.1%
9.8%
7.7%
6.2%
6.0%
5.7%
4.4%
3.2%
2.9%
2.6%
2.6%
2.3%
2.3%
2.1%
2.0%
1.7%
1.4%
1.1%
1.0%
1.0%
6.2%
97.4%
Source: Public Citizen, Pharmaceutical Industry Criminal and Civil Penalties: An Update.
Number of
Settlements+
20
15
14
27
12
13
7
7
1
12
12
19
1
2
1
3
1
14
4
10
108
303
▸ Many large pharmaceutical
companies have received
numerous fines over the
decades, with total
penalties in the billions
Valeant is notably absent
from this list
20View entire presentation